CSS adds Wasserman
This article was originally published in The Rose Sheet
Executive SummaryIvan Wasserman joins Washington, D.C.-based law firm Collier Shannon Scott as partner "to expand the firm's expertise on food and drug regulatory issues," CSS announces Feb. 10. As partner at Venable for the past year, Wasserman's work involved OTC drugs, dietary supplements and medical devices. As an associate at Arent Fox from 1996-2002, he worked with FDA on advertising issues. Wasserman specializes in labeling and advertising law, particularly for acne OTCs, sunscreens and external analgesic products...
You may also be interested in...
The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.